Cargando…

Cellular therapies in organ transplantation

Cellular therapy is a promising tool for improving the outcome of organ transplantation. Various cell types with different immunoregulatory and regenerative properties may find application for specific transplant rejection or injury‐related indications. The current era is crucial for the development...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hoogduijn, Martin J., Issa, Fadi, Casiraghi, Federica, Reinders, Marlies E. J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898347/ https://www.ncbi.nlm.nih.gov/pubmed/33207013 http://dx.doi.org/10.1111/tri.13789

Ejemplares similares

NK Cells and MSCs: Possible Implications for MSC Therapy in Renal Transplantation
por: Reinders, Marlies EJ, et al.
Publicado: (2014)

The emergence of regenerative medicine in organ transplantation: 1st European Cell Therapy and Organ Regeneration Section meeting
por: Hoogduijn, Martin J., et al.
Publicado: (2020)

Mesenchymal Stromal Cell-Based Therapy
por: Mönch, Dina, et al.
Publicado: (2023)

Mesenchymal Stromal Cell Therapy in Solid Organ Transplantation
por: Podestà, Manuel Alfredo, et al.
Publicado: (2021)

How to Make Sense out of 75,000 Mesenchymal Stromal Cell Publications?
por: Mönch, Dina, et al.
Publicado: (2022)

The current status of stem cell‐based therapies during ex vivo graft perfusion: An integrated review of four organs
por: Luijmes, Stefan H., et al.
Publicado: (2022)

Advanced in vitro Research Models to Study the Role of Endothelial Cells in Solid Organ Transplantation
por: Peelen, Daphne M., et al.
Publicado: (2021)

Mesenchymal Stem Cells in Transplantation and Tissue Regeneration
por: Hoogduijn, Martin J., et al.
Publicado: (2011)

A Decentralized Kidney Transplant Biopsy Classifier for Transplant Rejection Developed Using Genes of the Banff-Human Organ Transplant Panel
por: van Baardwijk, Myrthe, et al.
Publicado: (2022)

An Immune Atlas of T Cells in Transplant Rejection: Pathways and Therapeutic Opportunities
por: Short, Sarah, et al.
Publicado: (2023)

The Biological Effects of IL-21 Signaling on B-Cell-Mediated Responses in Organ Transplantation
por: Wu, Yongkang, et al.
Publicado: (2016)

Mesenchymal Stromal Cell Derived Membrane Particles Are Internalized by Macrophages and Endothelial Cells Through Receptor-Mediated Endocytosis and Phagocytosis
por: da Costa Gonçalves, Fabiany, et al.
Publicado: (2021)

Proteomic Analysis of Mesenchymal Stromal Cell-Derived Extracellular Vesicles and Reconstructed Membrane Particles
por: Tejeda-Mora, Hector, et al.
Publicado: (2021)

Homing of Regulatory T Cells to Human Skin Is Important for the Prevention of Alloimmune-Mediated Pathology in an In Vivo Cellular Therapy Model
por: Issa, Fadi, et al.
Publicado: (2012)

Are mesenchymal stromal cells immune cells?
por: Hoogduijn, Martin J
Publicado: (2015)

Safety and Efficacy Endpoints for Mesenchymal Stromal Cell Therapy in Renal Transplant Recipients
por: Bank, J. R., et al.
Publicado: (2015)

Lysophosphatidic Acid: Promoter of Cancer Progression and of Tumor Microenvironment Development. A Promising Target for Anticancer Therapies?
por: Aiello, Sistiana, et al.
Publicado: (2021)

Mesenchymal Stem Cells: Are We Ready for Clinical Application in Transplantation and Tissue Regeneration?
por: Hoogduijn, Martin J., et al.
Publicado: (2013)

Alemtuzumab induction therapy in solid organ transplantation
por: Friend, Peter J
Publicado: (2013)

Mesenchymal stem cell-educated macrophages
por: Eggenhofer, Elke, et al.
Publicado: (2012)

Relinquishing Anonymity in Living Donor Kidney Transplantation: Lessons Learned From the UK Policy for Anonymous Donors
por: Pronk, Mathilde C., et al.
Publicado: (2022)

Mesenchymal Stromal Cells for Transplant Tolerance
por: Podestà, Manuel Alfredo, et al.
Publicado: (2019)

Cellular immune therapy for viral infections in transplant patients
por: Khanna, Rajiv, et al.
Publicado: (2013)

Humanization of Immunodeficient Animals for the Modeling of Transplantation, Graft Versus Host Disease, and Regenerative Medicine
por: Adigbli, George, et al.
Publicado: (2020)

Cell-free DNA measurement of three genomes after allogeneic MSC therapy in kidney transplant recipients indicates early cell death of infused MSC
por: Dreyer, Geertje J., et al.
Publicado: (2023)

Immune Monitoring for Advanced Cell Therapy Trials in Transplantation: Which Assays and When?
por: Stark, Helen L., et al.
Publicado: (2021)

Allogeneic Hematopoietic Cell Transplantation and Cellular Therapy
por: Kim, Hee-Je, et al.
Publicado: (2021)

Fecal microbiota transplantation in hematopoietic cell transplant and cellular therapy recipients: lessons learned and the path forward
por: Habibi, Shaghayegh, et al.
Publicado: (2023)

Editorial: Safety, Efficacy and Mechanisms of Action of Mesenchymal Stem Cell Therapies
por: Moll, Guido, et al.
Publicado: (2020)

Cellular organization by self-organization: mechanisms and models for Min protein dynamics
por: Howard, Martin, et al.
Publicado: (2005)

Infusing Mesenchymal Stromal Cells into Porcine Kidneys during Normothermic Machine Perfusion: Intact MSCs Can Be Traced and Localised to Glomeruli
por: Pool, Merel, et al.
Publicado: (2019)

Cellular Transplantation for Liver Diseases
por: Jameson, Elizabeth
Publicado: (2008)

Cardiovascular Effects of Autologous Bone Marrow–Derived Mesenchymal Stromal Cell Therapy With Early Tacrolimus Withdrawal in Renal Transplant Recipients: An Analysis of the Randomized TRITON Study
por: Meucci, Maria Chiara, et al.
Publicado: (2021)

Translating tolerogenic therapies to the clinic – where do we stand?
por: Issa, Fadi, et al.
Publicado: (2012)

Current Status of Immunomodulatory and Cellular Therapies in Preclinical and Clinical Islet Transplantation
por: Chhabra, Preeti, et al.
Publicado: (2011)

Rationale for Surrogate Endpoints and Conditional Marketing Authorization of New Therapies for Kidney Transplantation
por: Naesens, Maarten, et al.
Publicado: (2022)

Direct detection of circulating donor-derived extracellular vesicles in kidney transplant recipients
por: Woud, Wouter W., et al.
Publicado: (2022)

On the interactions between mesenchymal stem cells and regulatory T cells for immunomodulation in transplantation
por: Engela, Anja U., et al.
Publicado: (2012)

The “New Caledonia COVID-19 Paradox”: Dramatic Indirect Impact of the Pandemic on Organ Donation and Transplantation in a Nonprevalence Country
por: Haidar, Fadi, et al.
Publicado: (2021)

Clinical and Molecular Profiling to Develop a Potential Prediction Model for the Response to Alemtuzumab Therapy for Acute Kidney Transplant Rejection
por: Hullegie‐Peelen, Daphne M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_34au7ujdm0dhsl5a45p7q7pq5b